Translational clinical trials: an entropy-based approach to sample size
- 1 April 2005
- journal article
- research article
- Published by SAGE Publications in Clinical Trials
- Vol. 2 (2) , 182-192
- https://doi.org/10.1191/1740774505cn078oa
Abstract
Translational clinical trials are small studies of therapies emerging from the laboratory. These trials are essential for generating early evidence regarding the effects of treatment on specific targets in the disease pathway and for guiding the next studies to be done. The statistical properties of such studies have been neglected, in part, because they do not fit the well-known clinical trials developmental paradigm. This paper discusses the translational trial setting, and presents an information (entropy) based approach to understanding the properties and use of these trials. The combination of biological knowledge with a designed experiment (albeit a small one) is a powerful device for resolving much of the considerable uncertainty surrounding an emerging therapeutic concept. An approach to motivating the sample size for translational trials is presented.Keywords
This publication has 13 references indexed in Scilit:
- Translational Medicine: A two-way roadJournal of Translational Medicine, 2003
- Translational Study in Cancer Research.Internal Medicine, 2002
- Translational research in clinical trials: the only way forwardEuropean Journal Of Cancer, 2001
- Translational research: What is it?Gastroenterology, 1999
- The continuing dilemma in clinical investigation and the future of American health careAcademic Medicine, 1996
- Translational research comes of ageNature Medicine, 1996
- On a Measure of the Information Provided by an ExperimentThe Annals of Mathematical Statistics, 1956
- On Information and SufficiencyThe Annals of Mathematical Statistics, 1951
- A Mathematical Theory of CommunicationBell System Technical Journal, 1948
- Theory of Statistical EstimationMathematical Proceedings of the Cambridge Philosophical Society, 1925